Dominika Lorek

Dominika Lorek

Auto-generated profile, based on publicly available information

Dominika Lorek

Collegium Medicum, Jan Kochanowski University, Kielce, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2025 in Archives of Virology
Verified
Journal Article
Open access
PDF file
KŁKrzysztof Łupina
Krzysztof Łupina
KNKlaudia Nowak
Klaudia Nowak
DLDominika Lorek
Dominika Lorek
ANAdrian Tomasz Nowak
Adrian Tomasz Nowak
ARAnna Romac
Anna Romac
JJJakub Janczura
Jakub Janczura
Human immunodeficiency virus (HIV) remains a global public health challenge, affecting millions worldwide despite significant advancements in antiretroviral therapy (ART). While ART has transformed HIV into a manageable chronic condition, long-term adherence, drug resistance, and access disparities continue to hinder treatment success. Recent research has focused on developing alternative therapeutic strategies, particularly long-acting injectable (LAI) therapies and immunotherapeutic approaches to improve adherence and potentially achieve viral remission. This review explores the evolution of pharmacological advancements in HIV treatment, highlighting the transition from daily oral ART to long-acting formulations such as cabotegravir, rilpivirine, and lenacapavir. LAI therapies reduce the burden of daily adherence, enhance treatment efficacy, and decrease stigma, particularly in vulnerable populations. Additionally, novel immunotherapeutic strategies such as broadly neutralizing antibodies, immune checkpoint inhibitors, and chimeric antigen receptor T cell therapy are being investigated for their potential to induce long-term viral suppression or cure. Despite these promising developments, several challenges remain, including resistance-associated mutations, accessibility issues, and long-term safety concerns. This review summarizes recent clinical trials, discusses the benefits and limitations of emerging HIV therapies, and outlines future research directions. The continued advancement of LAI therapies and immunotherapeutics holds great potential to improve treatment outcomes, expand global access to care, and move closer to a functional cure for HIV.

20 March 2025 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
DLDominika Lorek
Dominika Lorek
KŁKrzysztof Łupina
Krzysztof Łupina
WBWiktoria Bisaga
Wiktoria Bisaga
DMDominik Malicki
Dominik Malicki
WSWeronika Stępień
Weronika Stępień
JJJakub Janczura
Jakub Janczura
Metabolism-associated steatotic liver disease (MASLD) is the most prevalent chronic liver condition worldwide and affects nearly 30% of the global population. While traditionally associated with metabolic risk factors, such as obesity and insulin resistance, increasing attention is being directed toward socioeconomic and environmental determinants that contribute to disparities in MASLD prevalence and outcomes. Low-income populations often experience higher rates of MASLD owing to limited access to healthcare, poor diet quality, and reduced opportunities for physical activity. Conversely, high-income countries are witnessing a paradoxical rise in MASLD cases, driven by sedentary lifestyles and excessive consumption of ultra-processed foods. This review examined the effects of socioeconomic status, education, healthcare access, and environmental exposure on the epidemiology of MASLD. The findings revealed that individuals from lower socioeconomic backgrounds and migrant populations experience a disproportionately higher burden of MASLD due to systemic healthcare barriers, dietary transitions, and occupational exposure. Children and adolescents face increasing susceptibility owing to rising obesity rates, and geographic disparities highlight Europe as the most affected region, followed by Asia and North America. Given the growing public health impact of MASLD, addressing both socioeconomic and environmental determinants is essential. Future efforts should prioritize policy-driven interventions, including equitable healthcare access, lifestyle modifications, and research into novel therapeutic approaches to mitigate the disease burden and improve patient outcomes.

17 March 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
PSPiotr Starnawski
Piotr Starnawski
KNKlaudia Nowak
Klaudia Nowak
ZAZuzanna Augustyn
Zuzanna Augustyn
DMDominik Malicki
Dominik Malicki
APAleksandra Piąta
Aleksandra Piąta
JJJakub Janczura
Jakub Janczura

12 May 2026 in Annales Academiae Medicae Silesiensis
Verified
Journal Article
Open access
NDNatalia Dardzińska
Natalia Dardzińska
EOEmil ObręBski
Emil ObręBski
DLDominika Lorek
Dominika Lorek
PJPaulina Jaskulska
Paulina Jaskulska
NKNatalia Krzysztofek
Natalia Krzysztofek
BMBartosz Molasy
Bartosz Molasy
Intestinal intussusception in adults is a rare disorder, occurring in about 5% of cases. In the pediatric population, it is most often idiopathic in origin, while in adults it is associated with pathologies within the intestinal wall. The purpose of this study is to emphasize the need for expanded diagnosis in adult patients with symptoms of gastrointestinal obstruction due to intestinal intussusception. The medical records of a 22-year-old female patient hospitalized in the Department of General Surgery of St. Alexander Hospital in Kielce were analyzed. The patient presented to the hospital with complaints of abdominal pain accompanied by vomiting. She had a history of treatment for Hashimoto’s disease, iron deficiency anemia and gastritis. After initial diagnosis, the patient was transferred to the department of general surgery, where conservative treatment was implemented and gastroscopy was performed. During hospitalization, the patient was consulted in internal medicine due to uncompensated hypothyroidism. Due to lack of improvement, imaging studies were ordered, which revealed a dilated loop of small intestine with suspected intussusception. The patient was qualified for surgery, during which an intussusception of the jejunum was found. Due to the inability to drain the intussusception, a segmental small bowel resection was performed. Histopathological examination revealed a hamartomatous polyp as the cause of the intussusception. Given the overall clinical picture, the patient was referred to the genetic counseling center, where Cowden syndrome was confirmed. Intestinal intussusception, although rare, should be considered as a cause of gastrointestinal obstruction in adults. Identification of the pathological changes that are its cause is crucial to the overall diagnostic and therapeutic process.